Over the course of the past decade, a tremendous amount of progress has been made both socially and legally when it comes to the acceptance of cannabis as a substance. In years past, cannabis was outright vilified, made entirely illegal to even have in your possession, much less ingest in any way, shape, or form. This hard-lined bias dates all the way back to the 1930s, when government-funded propaganda films such as Reefer Madness were being released, in an effort to instill an innate fear in general consumers of cannabis-related products.
However, now, nearly a century later, such notions seem entirely outdated and irrelevant to many modern consumers. Cannabis has been legalized in several states, and is generally viewed in a less harmful, more neutral light by the larger population. As a result of this cannabis legalization expansion, there is a growing need for a testing method that can identify recent THC use rather than just past consumption. Fortunately, a bold new tool may be the exact fix people have been searching for, as breath-based THC testing is a potentially paradigm-shifting solution to that age-old problem.
Cannabix Technologies (BLOZF:OTCID, BLO:CSE) is developing a breath-based system that could help employers, law enforcement, and policymakers make fairer, more accurate decisions by focusing on possible current impairment instead of detecting cannabis use from days or weeks earlier.
The Issues with Current Testing
Today, the majority of drug testing tools utilize a sample of some kind from the person in question, whether urine, blood, or hair. However, these tests have routinely proven to be unreliable, especially when it comes to identifying when the consumption of cannabis occurred. These forms of testing are capable of confirming whether or not someone used marijuana days or even weeks after consumption, which is also a key part of the larger problem. In states where cannabis is legalized, there is no reason a worker should be punished for having consumed marijuana several days ago, so long as they are lucid and coherent on the job.
This mismatch poses growing challenges for employers, law enforcement, and public safety policymakers. In a world where cannabis is legal but operating heavy machinery while high is not, the distinction between past use and present influence is an incredibly important one. Thankfully, breath-based THC testing, such as that made possible by Cannabix Technologies’ latest product, offers a much-needed answer.
The Science of Recency: A Complex Puzzle
THC is the primary psychoactive compound found in cannabis, and it behaves in a very different way than other testable substances, such as alcohol. THC is fat-soluble, meaning it can remain detectable in the body long after its intoxicating effects have worn off. This makes conventional drug tests ill-suited for scenarios where the timing of consumption matters.
“There’s a clear need for tools that don’t just detect cannabis,” says Bryan Loree, CFO and Director at Cannabix Technologies, a company working at the forefront of this challenge. “We need tools that can detect recent use, ideally within a few hours.”
Breaking Outdated Perceptions
To address these issues, Cannabix has developed a unique breath-based collection device for use with laboratory-based gold-standard mass spectrometry analysis that aims to solve this problem. By focusing on detecting delta-9 THC specifically within a time window that aligns with psychoactive effects, the company is contributing to a new category of cannabis testing designed for fairer and more relevant testing capability.
Unlike blood or urine tests, breath analysis is non-invasive. It fits the increasing demand for portable breath-collection tools in healthcare, criminal justice, and workplace compliance. And with growing scrutiny of cannabis policies in legalized areas, the need for breath-based testing, combined with gold-standard mass spectrometry analysis, may soon become more common.
Final Thoughts
Though Cannabix Technologies certainly isn’t alone in pursuing breath-based THC detection, it is one of the few companies doing so with over a decade of hard-earned experience in the sector and deep technical credibility. These elements not only help improve the team’s potential findings and breakthroughs but also bolster the legitimacy with which their findings are ultimately viewed. The team includes biomedical engineers, medical imaging specialists, and forensic science experts.
Ultimately, the race isn’t just about who can build the device; it’s about who can validate it, scale it, and earn the trust of industry, regulators, and users alike. Cannabix Technologies appears well-positioned to do just that.
